ADMA BIOLOGICS INC
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
ADMA$12.79+0.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1B. Unresolved Staff Comments
| Item 1B. | Unresolved Staff Comments |
|---|
Not Applicable.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.